Salvatore Calabrese's most recent trade in Gain Therapeutics Inc was a trade of 50,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gain Therapeutics Inc | Salvatore Calabrese | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Gain Therapeutics Inc | Salvatore Calabrese | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Gain Therapeutics Inc | Salvatore Calabrese | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 59,400 | 59,400 | - | - | Employee Stock Option (right to buy) | |
| Gain Therapeutics Inc | Salvatore Calabrese | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 9,900 | 9,900 | - | - | Restricted Stock Units | |
| Gain Therapeutics Inc | Salvatore Calabrese | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 19 May 2022 | 3,000 | 3,000 | - | 2.7 | 8,100 | Common Stock |